S1 Pill - red oval, 21mm
Pill with imprint S1 is Red, Oval and has been identified as Mesalamine Delayed-Release 1.2 g. It is supplied by Chartwell RX, LLC.
Mesalamine is used in the treatment of Ulcerative Colitis, Active; Ulcerative Colitis, Maintenance; Crohn's Disease, Maintenance; Inflammatory Bowel Disease; Ulcerative Colitis and belongs to the drug class 5-aminosalicylates. excluding Asacol and Asacol HD: There is no proven risk in humans during pregnancy. Asacol and Asacol HD: Risk cannot be ruled out during pregnancy. Mesalamine 1.2 g is not a controlled substance under the Controlled Substances Act (CSA).
Images for S1
Mesalamine Delayed-Release
- Imprint
- S1
- Strength
- 1.2 g
- Color
- Red (light red to red)
- Size
- 21.00 mm
- Shape
- Oval (biconvex, film-coated)
- Availability
- Prescription only
- Drug Class
- 5-aminosalicylates
- Pregnancy Category
- B - No proven risk in humans - excluding Asacol and Asacol HD, C - Risk cannot be ruled out - Asacol and Asacol HD
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Chartwell RX, LLC
- Manufacturer
- Haimen Pharma Inc.
- National Drug Code (NDC)
- 62135-0714
Related images for "S1"
More about mesalamine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (426)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: 5-aminosalicylates
- Breastfeeding
Patient resources
- Mesalamine drug information
- Mesalamine rectal
- Mesalamine (Oral) (Advanced Reading)
- Mesalamine (Rectal) (Advanced Reading)
- Mesalamine Rectal Enema
- Mesalamine Suppositories
Other brands
Lialda, Pentasa, Apriso, Asacol HD, ... +4 more
Professional resources
- Mesalamine monograph
- Mesalamine (FDA)
- Mesalamine Capsules (FDA)
- Mesalamine Controlled-Release Capsules (FDA)
- Mesalamine Delayed Release Tablets (FDA)
Other brands
Lialda, Pentasa, Asacol, Apriso, ... +5 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.